North America Cancer Therapeutics Market Analysis, Share, Trend, Industry Report Forecast till 2031

The cancer therapeutics market size is expected to reach US$ 2,20,296.70 million by 2031 from US$ 96,352.25 million in 2024. The market is estimated to record a CAGR of 12.7% from 2025 to 2031.

The cancer therapeutics market in North America is experiencing significant growth driven by several key factors, including growing burden of breast and lung cancer and surging investments in oncology research. The North America medical device support arms market is segmented into the US, Canada, and Mexico. Canada is burdened with the rising incidence of cancer. According to the data published by Statistics Canada, ~0.23 million people in the country were diagnosed with cancer in 2022, and the disease caused ~0.08 million deaths.

Grab PDF To Know More @ https://www.businessmarketinsights.com/sample/BMIRE00031449?utm_source=OpenPR&utm_medium=10844

The most commonly diagnosed cancers in the Canadian population are lung, breast, prostate, and colorectal. As per the Canadian Cancer Society, ~28,600 women were diagnosed with breast cancer in 2022, representing 25% of new cancer cases in women in the country. Nearly one in eight Canadian women is estimated to develop breast cancer during their lifespan. The Canadian government's commitment to advancing cancer treatment is evident through programs such as the Canadian Cancer Research Alliance (CCRA), which has invested in research and the development of new therapies. Drugs, such as Keytruda, are gaining traction, offering patients more effective treatments with fewer side effects.

MARKET INTRODUCTION

The North America medical device support arms market is segmented into the US, Canada, and Mexico. North America, particularly the US, records a high prevalence of cancer; moreover, a large aging population is at a greater risk of the disease. The rising number of cancer cases fuels the demand for advanced therapeutics and treatment options. The cancer therapeutics market in Mexico is experiencing significant growth owing to demographic, economic, and healthcare infrastructure improvements. As per the data published by the International Agency for Research on Cancer (IARC), ~0.21 million new cancer cases were reported in Mexico in 2022, wherein the major cancer was breast cancer, accounting for 15.0% of all reported cases, followed by prostate cancer. An increasing number of cancer cases leads to an upsurge in the demand for innovative treatments, boosting the cancer therapeutics market through advancements in drug development and personalized medicine, and investments in research and healthcare infrastructure.

List of Companies Profiled in the North America Cancer Therapeutics Market Report are:

• The World Bank World Development Indicators
• World Health Organization (WHO)
• Global Cancer Observatory
• American Cancer Society
• American Society of Clinical Oncology
• National Cancer Institute

Read Full Reports@ https://www.businessmarketinsights.com/reports/north-america-cancer-therapeutics-market

Key Segmentation:

Key segments that contributed to the derivation of the cancer therapeutics market analysis are type and application.

• By therapy type, the cancer therapeutics market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapy types. The chemotherapy segment dominated the market in 2024.
• In terms of indications, the market is segmented into blood cancer, lung cancer, breast cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. The lung cancer segment held the largest share of the market in 2024.
• By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online stores. The hospital pharmacies segment held the largest share of the market in 2024.

Table of Contents

1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. North America Cancer Therapeutics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users
5. North America Cancer Therapeutics Market - Key Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Prevalence of Cancer
5.1.2 Favorable Reimbursement Scenario for Novel Therapeutics
5.1.3 Improvement in Diagnosis Rate of Cancer
5.2 Market Opportunities
5.2.1 Government Intervention across Developing Nations to Improve the Access of Life-saving Drugs
5.2.2 Rising Investments in the Development of Advanced Drug Development Platforms
5.2.3 Growing Number of Clinical trials for Anticancer Drugs
5.3 Future Trends
5.3.1 Emergence of Advanced Cell & Gene Therapies
5.3.2 Rising Adoption of Precision Medicine and Personalized Therapeutics
5.3.3 Improvement in Diagnosis Rate of Cancer
5.4 Impact of Drivers and Restraints
6. North America Cancer Therapeutics Market Regional Analysis
6.1 North America Cancer Therapeutics Market Overview
6.2 North America Cancer Therapeutics Market Revenue 2022-2031 (US$ Million)
6.3 North America Cancer Therapeutics Market Forecast Analysis and many more ...

Contact us:
If you have any questions about this report or would like further information, please contact us:
Contact person: Ankit Mathur
Email: sales@businessmarketinsights.com
Phone: +16467917070

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defence; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

This release was published on openPR.